A detailed history of Sand Grove Capital Management LLP transactions in Catalent, Inc. stock. As of the latest transaction made, Sand Grove Capital Management LLP holds 429,848 shares of CTLT stock, worth $27.3 Million. This represents 10.49% of its overall portfolio holdings.

Number of Shares
429,848
Previous 487,194 11.77%
Holding current value
$27.3 Million
Previous $27.4 Million 4.96%
% of portfolio
10.49%
Previous 8.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $3.22 Million - $3.5 Million
-57,346 Reduced 11.77%
429,848 $26 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $16.3 Million - $17.4 Million
304,874 Added 167.22%
487,194 $27.4 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $7.76 Million - $10.9 Million
182,320 New
182,320 $10.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Sand Grove Capital Management LLP Portfolio

Follow Sand Grove Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Grove Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sand Grove Capital Management LLP with notifications on news.